Canada vs Myanmar: Share of the population living with HIV receiving antiretroviral therapy
Canada
76.2%
in 2022
Myanmar
74.7%
in 2024
Canada rank
62nd
Myanmar rank
65th
Share of the population living with HIV receiving antiretroviral therapy over time
- Canada
- Myanmar
How they compare
Canada currently reports 76.2% against 74.7% in Myanmar, a difference of 1.5%.
The two have swapped places 1 time across 33 shared years of data; in 1990 it was Myanmar ahead.
Canada ranks 62nd and Myanmar ranks 65th of 149 countries.
Canada has averaged higher in every one of the 4 decades both report.
Head to head by decade
| Decade | Canada | Myanmar | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 4.0% | 0.0% | 4.0% | Canada |
| 2000s | 30.6% | 2.4% | 28.2% | Canada |
| 2010s | 64.2% | 37.6% | 26.6% | Canada |
| 2020s | 77.4% | 71.6% | 5.9% | Canada |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher share of the population living with hiv receiving antiretroviral therapy, Canada or Myanmar?
- Canada, at 76.2% against 74.7% in Myanmar as of 2022.
- What is the difference in share of the population living with hiv receiving antiretroviral therapy between Canada and Myanmar?
- 1.5%, with Canada ahead.
- How many years of comparable data are there for Canada and Myanmar?
- 33 years are reported by both, from 1990 to 2022.
- How do Canada and Myanmar rank globally for share of the population living with hiv receiving antiretroviral therapy?
- Canada ranks 62nd and Myanmar ranks 65th of 149 countries.
- Where does this data come from?
- Joint United Nations Programme on HIV/AIDS (2026) – with minor processing by Our World in Data, published as Share of the population living with HIV receiving antiretroviral therapy. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Percentage of individuals diagnosed with HIV who are currently receiving antiretroviral therapy. This is the central estimate.